Compared to ADAM17, ADAM10 expression was significantly lower in both tumor regions, with higher levels in TC compared to IC within MIBC (p = 0.004) and CIS (p = 0.007) (Figure 3A,C). The gene discussed is ADAM17; the disease is in situ carcinoma.